There is nothing worse for a patient, from a psychological and human standpoint, than being severely ill or even dying from a disease, when experimental treatments are out there, pending final evaluation.
Nowadays, patients are aware of new product developments; research is no longer a secret. In some countries, regulators have responded to this situation, and medicines can be obtained on a Compassionate Use basis prior to their marketing authorisation, to help treat patients who have no other options and who do not have the time to wait for the end of clinical trials and the authorisation process.
These pages inform patients and healthcare professionals about Compassionate Use possibilities. Compassionate Use can save lives.